Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • pharma news

    Tag: pharma news

    You Searched For "pharma news"
    Rochester Drug Cooperative fined $20 million in criminal case against drug distributor over opioids

    Rochester Drug Cooperative fined $20 million in criminal case against drug distributor over opioids

    Medical Dialogues Bureau24 April 2019 9:00 AM IST
    The company where the executives worked, Rochester Drug Cooperative (RDC), is one of the country's largest distributors of prescription opioids. It...
    Mylan, TB Alliance to commercialize Pretomanid to treat TB

    Mylan, TB Alliance to commercialize Pretomanid to treat TB

    Farhat Nasim23 April 2019 10:00 AM IST
    TB Alliance began preclinical development of pretomanid in 2002, and it has since studied pretomanid in 20 clinical trials alone or in combination...
    Eli Lilly to sell legacy antibiotics brands Ceclor, Vancocin, China facility to Eddingpharm

    Eli Lilly to sell legacy antibiotics brands Ceclor, Vancocin, China facility to Eddingpharm

    Farhat Nasim23 April 2019 9:45 AM IST
    INDIANAPOLIS: Eli Lilly and Company today announced that it has entered into an agreement to sell the rights in China for two legacy Lilly antibiotic...
    Cipla appoints Dr Raju Mistry as Global Chief People Officer

    Cipla appoints Dr Raju Mistry as Global Chief People Officer

    Medical Dialogues Bureau23 April 2019 9:15 AM IST
    In her role at Cipla, Raju Mistry will oversee Human Resources, and Administration and Facilities Management. She will be a member of the Management...
    Drugs registered on SUGAM portal to be exempted from obtaining licence for purpose of examination, test, analysis

    Drugs registered on SUGAM portal to be exempted from obtaining licence for purpose of examination, test, analysis

    Meghna A Singhania21 April 2019 2:26 PM IST
    The exemption from obtaining a licence for Form 29 is subject to the condition that the information about the manufacturing of approved drugs for...
    Lower dose of Pfizer, Eli Lilly blockbuster painkiller tanezumab misses target in late stage study

    Lower dose of Pfizer, Eli Lilly blockbuster painkiller tanezumab misses target in late stage study

    Farhat Nasim20 April 2019 10:00 AM IST
    The drug, tanezumab, belongs to a new category of pain medications that target nerve growth factor, a protein involved in the growth of nerve cells,...
    Government to revise limit of free salicylic acid content in drugs containing ASPIRIN

    Government to revise limit of free salicylic acid content in drugs containing ASPIRIN

    Meghna A Singhania18 April 2019 3:13 PM IST
    New Delhi: Government is soon going to revise the limit of free salicylic acid content in medicines containing Aspirin, as the Drugs and Techincal...
    Ministry of AYUSH invites initial bids for strategic sale of IMPCL

    Ministry of AYUSH invites initial bids for strategic sale of IMPCL

    Garima18 April 2019 10:15 AM IST
    If the strategic sale of Indian Medicines Pharmaceutical Corporation Ltd (IMPCL), under the Ministry of AYUSH goes through the proceeds, would add to...
    Zydus Cadila announces phase III trials of Desidustat to treat non-dialysis anaemia

    Zydus Cadila announces phase III trials of Desidustat to treat non-dialysis anaemia

    Farhat Nasim17 April 2019 9:45 AM IST
    Zydus Cadila Group Chairman Pankaj R Patel said this innovation has the potential to bring about a paradigm shift in the management of CKD patients...
    Alchem solves stability dilemma for micronized DIGOXIN; files PATENT for novel production process

    Alchem solves stability dilemma for micronized DIGOXIN; files PATENT for novel production process

    Meghna A Singhania16 April 2019 4:47 PM IST
    Alchem's molecule is the sole micronized digoxin available globally that resolves the challenge of micro dosage formulation and the long-term...
    Cipla, Pulmatrix join hands to co-develop Pulmazole for treating asthma

    Cipla, Pulmatrix join hands to co-develop Pulmazole for treating asthma

    Garima16 April 2019 9:40 AM IST
    Pulmazole an inhaled iSPERSE formulation of the antifungal drug itraconazole for the treatment of allergic bronchopulmonary aspergillosis (ABPA) in...
    Alembic Pharma receives USFDA nod for Bimatoprost Ophthalmic Solution

    Alembic Pharma receives USFDA nod for Bimatoprost Ophthalmic Solution

    Farhat Nasim15 April 2019 10:05 AM IST
    Bimatoprost Ophthalmic Solution, 0.03% is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok